Steven J. Shulman, our Chief Executive Officer and a Director since inception, has over 45 years of experience leading and acquiring businesses in the healthcare industry. Mr Shulman is currently the Chairman of Magellan where he previously served as Chief Executive Officer from 2002 to 2008 and spearheaded its turnaround and restructuring following bankruptcy. Magellan is now a leader in managing what we believe are among the fastest growing, most complex areas of health, including special populations and other specific areas of healthcare. Mr. Shulman also currently serves as Chairman of Quartet Health, Inc., a healthcare technology company which connects primary care and mental health providers, a position he has held since 2014, CareCentrix, Inc., a post-acute managed care company, a position he has held since 2008 and Co-Chairman of Healthmap Solutions Inc., a health management company focused on progressive diseases, since 2018. He is also the Managing Partner at Shulman Family Ventures, Inc., a healthcare-focused private equity firm, a position he has held since 2008. In the last five years, he has served as a Director of several other privately-held companies, including VillageMD, a primary care medical management company, MedImpact, the largest privately held prescription drug benefits management company, Healthmarkets, a healthcare distribution and specialty insurance company, Pager, a digital health company and Facet Technologies, an OEM of lancets and lancing devices for diabetics. Previously, from 2013 to 2018, Mr. Shulman served as Chairman of the Board of R1 RCM Inc., a technology-enabled revenue cycle management service for healthcare providers and from 2013 to 2014 as Chairman of Health Management Associates, Inc., a hospital company. He served as an Operating Partner at Water Street Healthcare Partners, LLC from 2008 until 2015 and Tower Three Partners LLC from 2008 until 2013. He also served as Chairman and Chief Executive Officer of Internet Healthcare Group, LLC from 2000 to 2002 and as Chairman, President and Chief Executive Officer of Prudential Healthcare, Inc. from 1997 to 1999. Prior to that, Mr. Shulman served in senior executive positions at Value Health, Inc., a specialty managed care company he founded and took public, including as a Director and as President of the Pharmacy and Disease Management Group. He also previously held senior executive positions at each of Cigna Corporation, including as President of the East Central Division, and Kaiser Permanente, an integrated managed-care company, including as Director, Medical Economics. He received his Bachelor’s degree in Economics and Master’s degree in Health Services Administration from the State University of New York at Stony Brook. Mr. Shulman is well-qualified to serve as a Director due to his extensive operational, investment and board experience in the healthcare industry.
Charles J. Ditkoff, our President since inception, is also one of our directors as of the effective date of the registration statement of which this prospectus forms part. Since 2017, he has served as Senior Advisor to MTS, where he advises healthcare clients on all aspects of major corporate transactions, including mergers, acquisitions, divestitures and going-private transactions as well as regulatory, reimbursement and operational issues. Since 2016, Mr. Ditkoff has also been a Senior Advisor at FTI Consulting, Inc. where he drives relationships with healthcare organizations and private equity firms, and since 2017 he has been Senior Advisor to Ares Management Corporation, and since 2012, Mr. Ditkoff has also served as Senior Advisor at The Marwood Group, a healthcare-focused advisory and consulting firm. He also currently serves as counsel at McDermott, Will & Emery, a position he has held since 2012. In addition, since 2013, Mr. Ditkoff has been a director of Cumberland Consulting Group, LLC, a healthcare consulting and services firm providing strategic advisory consulting services, IT professional services, outsourced managed services and analytics solutions to clients in the payer, provider and life sciences markets. Previously, from 2010 to 2012, Mr. Ditkoff was Vice Chairman and Head of Global Healthcare Corporate and Investment Banking at Bank of America Merrill Lynch. Previously, he worked at Morgan Stanley and Credit Suisse. Prior to that, he was an Associate at Cravath, Swaine and Moore where he practiced corporate securities law. He holds a B.A. degree from Brown University and a J.D. degree from Yale Law School.
Dennis M. Conroy, our Chief Financial Officer since inception, has over 20 years of financial experience. Since 2013, Mr. Conroy has served as Chief Financial Officer for MTS Health Partners, LP, and since 2016 as Chief Operating Officer. Before MTS, he served as Senior Vice President of Finance at Rice Financial Products Company, a public finance focused investment bank, from 2008 to 2013. Prior to that, from 1998 to 2008, Mr. Conroy held a variety of roles at Gilman Ciocia, Inc., a provider of federal, state, and local tax preparation and financial planning services, including Chief Accounting Officer and Chief Financial Officer of its brokerage division. Mr. Conroy holds an M.B.A from The Lublin School of Business at Pace University and a B.S. in accounting from the State University of New York.
James C. Cowles serves as one of our directors as of the effective date of the registration statement of which this prospectus forms part. Until his retirement in December 2018, he was the Chief Executive Officer for Europe, Middle East & Africa (EMEA) at Citigroup, Inc. (NYSE:C), a position he had held since 2013. Prior to assuming this position, Mr. Cowles had served as Chief Operating Officer for EMEA and Head of Western Europe at Citigroup. He had also served as Head of Markets for Citi in EMEA, Global Head of Equities and Global Head of Equity Capital Markets (new-issue product). Mr. Cowles joined Smith Barney in 1979, which eventually became part of Citigroup as a result of several transactions. Other roles he held during his career have included: Head of Equities (EMEA), Deputy Head of Investment Banking, Head of Real Estate Investment Banking and Commercial Mortgage Trading, Head of Debt Capital Markets and Head of Direct Investments. Since 2019, he has served on the board of the following private companies: Kroptek, an agricultural technology company; Finconecta, a fintech platform seeking to integrate different components of the financial system; and Shieldpay, an online secure payments and escrow services provider. Mr. Cowles graduated Phi Beta Kappa from Denison University with a B.A. in economics, and holds an M.B.A. from The Wharton School, University of Pennsylvania. He is well-qualified to serve as a director due to his extensive experience in banking, finance and investment.
David H. Glaser serves as one of our directors as of the effective date of the registration statement of which this prospectus forms part. Until his retirement in 2019, he was Chief Operating Officer of Bank of America Merrill Lynch’s Global Corporate and Investment Bank (“GCIB”), which encompasses investment banking, capital markets, large cap corporate lending, treasury services and leasing activities, a position he had held since 2010. Mr. Glaser was Chairman of the GCIB Fairness Opinion Committee and a member of the GCIB Operating Committee. Prior to being Chief Operating Officer, he was Global Deputy Head of GCIB’s Mergers & Acquisitions Group and Chairman of Bank of America Securities Mergers and Acquisitions Group. Prior to joining Bank of America Securities in 2008, Mr. Glaser spent 23 years at Bear Stearns. During his tenure at Bear Stearns, he was at various times Co-Head of Investment Banking, Co-Head of Mergers and Acquisitions, a member of the Firm Management and Compensation Committee, Co-Chairman of the Firm Risk Committee, member of the Board of Directors of Bear Stearns & Co, Chairman of the Investment Banking Commitments Committee, a member of the Merchant Banking Investment Committee and Chairman of the Fairness Opinion Committee. Prior to joining Bear Stearns, Mr. Glaser spent three years as a mergers and acquisitions attorney at Skadden, Arps, Slate, Meagher & Flom. Mr. Glaser holds J.D. and M.B.A. degrees from the University of Chicago and an A.B. from Columbia. He is well-qualified to serve as a director due to his extensive experience in banking, finance and investment.
Rick Matros serves as one of our directors as of the effective date of the registration statement of which this prospectus forms part, has served as Chairman of the Board, President and Chief Executive Officer of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) since 2010. He was Chairman of the board of directors and Chief Executive Officer of Sun Healthcare Group, Inc. from 2001 until the transaction which created Sabra. Mr. Matros founded and served as Chief Executive Officer and President of Bright Now! Dental, a dental care provider, from 1998 to 2000 and as a director from 1998 until its sale in 2010. From 1998 until the sale of its operations in 2006, Mr. Matros was also a member of CareMeridian, LLC, a healthcare company that specialized in offering subacute and skilled nursing for patients suffering from traumatic brain injury, spinal cord injury and other catastrophic injuries, where he also served on the management committee. Previously, from 1994 to 1997, he served Regency Health Services, Inc., a publicly held long-term care operator, holding positions as Chief Executive Officer, President, director and Chief Operating Officer. Prior to that time, from 1988 to 1994, he served at Care Enterprises, Inc., holding positions as Chief Executive Officer, President, Chief Operating Officer, director and Executive Vice President—Operations. Mr. Matros has served on the executive board for RFE Investment Partners since 2009 and as the Executive Producer of Sabra Films, LLC since 2012. Mr. Matros holds a B.A. degree from Alfred University, and a M.S. in Gerontology from the University of Southern California. He is well-qualified to serve as a director due to his extensive operational and investment experience in the healthcare industry.